David V. Elkins net worth and biography

David Elkins Biography and Net Worth

David Elkins is the executive vice president and chief financial officer responsible for Global Business Operations, which includes Business Insights and Analytics, Global Finance and Global Procurement. David also currently serves as the executive sponsor of the company’s PRIDE Alliance People and Business Resource Group. 

 

“Our team creates incredible partnerships across the business to secure and build value for the company and our patients. Our team also plays a vital part in promoting health — our financial health,” says David. “It is our role to ensure we strategically and efficiently invest and deploy our resources in a manner that maximizes value for our patients and all our other stakeholders as we advance the need for innovative medicines.”

 

David joined Celgene in July 2018 after several years at Johnson & Johnson (J&J), where he served as chief financial officer for that company’s Consumer Products, Medical Devices and Corporate Functions. Prior to J&J, his experiences include EVP & chief financial officer of Becton, Dickinson and Company, a public global medical technology company. From 1995 to 2008, he held roles of increasing responsibility at AstraZeneca, and he began his career in finance at the Boeing Company in 1991. 

 

David earned his bachelor’s degree from the University of Delaware, an MS from the University of Pennsylvania, and an MBA from Drexel University.

What is David V. Elkins' net worth?

The estimated net worth of David V. Elkins is at least $7.48 million as of September 13th, 2022. Mr. Elkins owns 100,460 shares of Bristol-Myers Squibb stock worth more than $7,482,261 as of February 6th. This net worth approximation does not reflect any other assets that Mr. Elkins may own. Learn More about David V. Elkins' net worth.

What is David V. Elkins' salary?

As the CFO of Bristol-Myers Squibb, Mr. Elkins earned a total compensation package of $7,895,060.00 in 2021. Mr. Elkins earned a salary of $1,027,005.00, a bonus of $525,000.00, stock awards of $4,716,137.00, non-equity compensation of $1,342,169.00, and other compensation of $284,749.00. Learn More on David V. Elkins' salary.

How do I contact David V. Elkins?

The corporate mailing address for Mr. Elkins and other Bristol-Myers Squibb executives is 430 E. 29TH STREET 14 FLOOR, NEW YORK NY, 10016. Bristol-Myers Squibb can also be reached via phone at (212) 546-4000 and via email at [email protected] Learn More on David V. Elkins' contact information.

Has David V. Elkins been buying or selling shares of Bristol-Myers Squibb?

David V. Elkins has not been actively trading shares of Bristol-Myers Squibb during the past quarter. Most recently, David V. Elkins sold 133,951 shares of the business's stock in a transaction on Tuesday, September 13th. The shares were sold at an average price of $71.30, for a transaction totalling $9,550,706.30. Following the completion of the sale, the chief financial officer now directly owns 100,460 shares of the company's stock, valued at $7,162,798. Learn More on David V. Elkins' trading history.

Who are Bristol-Myers Squibb's active insiders?

Bristol-Myers Squibb's insider roster includes Mark Alles (CEO), Christopher Boerner (EVP), Giovanni Caforio (CEO), Adam Dubow (SVP), Joseph Eid (SVP), John Elicker (EVP), David Elkins (CFO), Sandra Leung (EVP), Dinesh Paliwal (Director), Karen Santiago (SVP), Louis Schmukler (EVP), Rupert Vessey (EVP), and Paul von Autenried (EVP). Learn More on Bristol-Myers Squibb's active insiders.

Are insiders buying or selling shares of Bristol-Myers Squibb?

During the last year, insiders at the biopharmaceutical company sold shares 13 times. They sold a total of 556,779 shares worth more than $40,131,837.38. The most recent insider tranaction occured on November, 9th when EVP Ann Powell sold 16,250 shares worth more than $1,307,312.50. Insiders at Bristol-Myers Squibb own 0.1% of the company. Learn More about insider trades at Bristol-Myers Squibb.

Information on this page was last updated on 11/9/2022.

David V. Elkins Insider Trading History at Bristol-Myers Squibb

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2022Sell133,951$71.30$9,550,706.30100,460View SEC Filing Icon  
8/12/2021Sell99,691$66.95$6,674,312.45View SEC Filing Icon  
See Full Table

David V. Elkins Buying and Selling Activity at Bristol-Myers Squibb

This chart shows David V Elkins's buying and selling at Bristol-Myers Squibb by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bristol-Myers Squibb Company Overview

Bristol-Myers Squibb logo
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.
Read More

Today's Range

Now: $74.53
Low: $74.23
High: $75.18

50 Day Range

MA: $74.43
Low: $71.01
High: $81.13

2 Week Range

Now: $74.53
Low: $65.00
High: $81.43

Volume

7,072,532 shs

Average Volume

8,579,685 shs

Market Capitalization

$158.46 billion

P/E Ratio

25.26

Dividend Yield

3.06%

Beta

0.43